Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
12 Sep 24
10-Q
2025 Q1
Quarterly report
15 Aug 24
NT 10-Q
Notice of late quarterly filing
14 Aug 24
10-K
2024 FY
Annual report
17 Jul 24
NT 10-K
Notice of late annual filing
28 Jun 24
10-Q
2024 Q3
Quarterly report
20 Feb 24
NT 10-Q
Notice of late quarterly filing
14 Feb 24
10-Q
2024 Q2
Quarterly report
21 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
8-K
Unregistered Sales of Equity Securities
20 Oct 23
8-K
Departure of Directors or Certain Officers
16 Oct 23
8-K
Entry into a Material Definitive Agreement
19 Sep 23
10-Q
2024 Q1
Quarterly report
15 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-K
2023 FY
Annual report
10 Jul 23
NT 10-K
Notice of late annual filing
29 Jun 23
8-K
Departure of Directors or Certain Officers
21 Jun 23
10-Q
2023 Q3
Quarterly report
14 Feb 23
10-Q
2023 Q2
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
8-K
Entry into a Material Definitive Agreement
7 Oct 22
UPLOAD
Letter from SEC
20 Sep 22
10-K/A
2022 FY
Annual report (amended)
14 Sep 22
CORRESP
Correspondence with SEC
14 Sep 22
UPLOAD
Letter from SEC
12 Sep 22
8-K
Alterola Biotech Signs Letter of Intent with Bright Green for Strategic Partnership to Advance Development of Pharmaceutical-Grade Cannabis
1 Sep 22
10-Q
2023 Q1
Quarterly report
18 Aug 22
NT 10-Q
Notice of late quarterly filing
16 Aug 22
UPLOAD
Letter from SEC
1 Aug 22
8-K
Alterola Biotech Inc. (OTC Markets ABTI) Announces Stop Transfer Legend Application to certain shares on its Shareholder Register
6 Jul 22
10-K
2022 FY
Annual report
10 Jun 22
8-K
Departure of Directors or Certain Officers
18 May 22
8-K
Departure of Directors or Certain Officers
10 May 22
EFFECT
Notice of effectiveness
21 Apr 22
CORRESP
Correspondence with SEC
18 Apr 22
UPLOAD
Letter from SEC
15 Apr 22
S-1
IPO registration
7 Apr 22
10-Q
2022 Q3
Quarterly report
1 Mar 22
NT 10-Q
Notice of late quarterly filing
15 Feb 22